New drug SIM0811 put to the test in healthy volunteers
NCT ID NCT07345364
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This early-stage study is testing a new drug, SIM0811, in 72 healthy Chinese adults to see if it is safe and how the body processes it. Participants receive a single dose of the drug or a placebo, and researchers monitor side effects and measure drug levels in the blood. The goal is to gather safety information before testing the drug in people with a medical condition.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTH, SUBJECTIVE are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Qilu Hospital of Shandong University
RECRUITINGJinan, Shandong, 250100, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Drug interaction study reveals how itraconazole and rifampin alter HMPL-453 levels
- Essential oil pills: do capsules change how they work?
- Scientists investigate body Fats' role in breast cancer and weight
- Healthy volunteers help test new Drug's safety
- Mindfulness program aims to ease stress for head start teachers
- Can cleaning up streets and filling tax forms boost health? philly study aims to find out